Annual Drug Patent Expirations for REZUROCK
Rezurock is a drug marketed by Kadmon Pharms Llc and is included in one NDA. There are four patents protecting this drug.
This drug has thirty-seven patent family members in twenty countries.
The generic ingredient in REZUROCK is belumosudil mesylate. Additional details are available on the belumosudil mesylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
